UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in short bowel and how to avoid them

Simon Gabe, Jeremy Nightingale, Siddhartha Oke

Summary

AI Generated

Short bowel syndrome, a condition following intestinal resection with lifelong consequences, has an incidence of 2 per million in Europe and is often initially managed in secondary care settings that lack specialist expertise.

  • Short bowel syndrome occurs after single or multiple intestinal resections.
  • The condition carries lifelong morbidity and mortality.
  • In Europe, the incidence is 2 per million of the population.
  • Initial recognition and management in adults typically occurs postoperatively in secondary care settings.
  • Specialist input from clinicians experienced in short bowel is often lacking in these secondary care settings.
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9
1.
Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124: 1111–1134. [Link]
2.
Mughal M, Irving M. Home parenteral nutrition in the United Kingdom and Ireland. Lancet 1986; 328: 383–387. [Link]
3.
Bakker H. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN-Home Artif Nutr Work Group Clin Nutr 1999; 18: 135–140. [Link]
4.
Gondolesi GE. Intestinal transplantation outcomes. Mt Sinai J Med 2012; 79: 246–255. [Link]
5.
Ahrens EJ, Blankenhorn D, Hirsch J. Measurement of the human intestinal length in vivo and some causes of variation. Gastroenterology 1956; 31: 274–284. [Link]
6.
Nightingale J, Lennard-Jones J. The short bowel syndrome: what’s new and old? Dig Dis 1993; 11: 12–31. [Link]
7.
Underhill BM. Intestinal length in man. Br Med J 1955; 2: 1243–1246. [Link]
8.
NICE. Clinical guideline [CG174]: Intravenous fluid therapy in adults in hospital, https://www.nice.org.uk/guidance/cg174/chapter/1-Recommendations#routine-maintenance-2 (2017, accessed 13 February 2018). [Link]
9.
Gabe SN. Small intestine. In: Standring S (ed.) Gray’s Anatomy : The anatomical basis of clinical practice. Elsevier Ltd, 2016, pp. 1124–1129. [Link]
10.
Baker ML, Williams R, Nightingale JMD. Causes and management of a high-output stoma. Colorectal Dis 2011; 13: 191–197. [Link]
11.
Gabe SM. OP033 The management of patients with high output enterocutaneous fistulae: A European survey. Clinical Nutrition Supplements 2012; 7: 14–15. [Link]
12.
Vallee BL, Wacker W, Ulmer DD. The magnesium-deficiency tetany syndrome in man. N Engl J Med 1960; 262: 155–161. [Link]
13.
Yu ASL, Yarlagadda SG. Hypomagnesemia: Clinical manifestations of magnesium depletion - UpToDate. UpToDate, https://www.uptodate.com/contents/hypomagnesemia-clinical-manifestations-of-magnesium-depletion (2025, accessed 13 February 2018). [Link]
14.
Staun M. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr 2009; 28: 467–479. [Link]
15.
Nightingale J. Guidelines for management of patients with a short bowel. Gut 2006; 55: 1–12. [Link]
16.
Pironi L. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr 2016; 35: 247–307. [Link]
17.
American Medical Association. Guidelines for essential trace element preparations for parenteral use: A statement by the Nutrition Advisory Group. J Parenter Enter Nutr 1979; 3: 263–267. [Link]
18.
Nightingale JM. Jejunal efflux in short bowel syndrome. Lancet 1990; 336: 765–768. [Link]
19.
Newton CR. Incidence and treatment of sodium depletion in ileostomists. Scand J Gastroenterol Suppl 1982; 74: 159–160. [Link]
20.
Newton CR. Effect of different drinks on fluid and electrolyte losses from a jejunostomy. J R Soc Med 1985; 78: 27–34. [Link]
21.
Lennard-Jones JE. Oral rehydration solutions in short bowel syndrome. Clin Ther 1990; 12: 129-137. [Link]
22.
Nightingale JM. Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution, and glucose polymer electrolyte solution. Gut 1992; 33: 759–761. [Link]
23.
Awouters F, Niemegeers C, Janssen PAJ. Pharmacology of antidiarrheal drugs. Annu Rev Pharmacol Toxicol 1983; 23: 279–301. [Link]
24.
Remington M, Fleming C, Malagelada J. Inhibition of postprandial pancreatic and biliary secretion by loperamide in patients with short bowel syndrome. Gut 1982; 23: 98–101. [Link]
25.
Lennard-Jones JE. Review article: practical management of the short bowel. Aliment Pharmacol Ther 1994; 8: 563–577. [Link]
26.
European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC). PRAC recommendations on signals, http://www.ema.europa.eu/docs/en_GB/document_library/PRAC_recommendation_on_signal/2017/03/WC500223722.pdf. (2017, accessed 20 October 2017). [Link]
27.
Food and Drug Admisitration (FDA). FDA Drug Safety Communication: FDA limits packaging for anti-diarrhea medicine Loperamide (Imodium) to encourage safe use, https://www.fda.gov/Drugs/DrugSafety/ucm594232.htm. (2018, accessed 15 February 2027). [Link]
28.
Nightingale JM. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 1991; 5: 405–412. [Link]
29.
Nightingale JM. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther 1989; 3: 367–373. [Link]
30.
Farthing MJ. Octreotide in dumping and short bowel syndromes. Digestion 1993; 54: 47–52. [Link]
31.
McIntyre P, Fitchew M. L-J. Patients with a high jejunostomy do not need a special diet. Gastroenterology 1986; 91: 25–33. [Link]
32.
Oke S, Walter MNM, Ansari T, et al. Growth factors and their use in short bowel. Curr Opin Gastroenterol 2017; 33: 212. [Link]
33.
Iyer KR, Kunecki M, Boullata JI, et al. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome. J Parenter Enter Nutr 2017; 41: 946–951. [Link]
34.
Schwartz LK, O’Keefe SJD, Fujioka K, et al. Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome. Clin Transl Gastroenterol 2016; 7: e142. [Link]
35.
Oke S, Nightingale J, Jeppesen J, et al. British Intestinal Failure Alliance (BIFA) position statement use of GLP-2 analogues and other growth factors for adult patients with intestinal failure., www.bapen.org.uk/pdfs/bifa/position-statements/use-of-glp-2-analogues-and-other-growth-factors-for-adult-patients-with-intestinal-failure.pdf (2023, accessed 26 June 2025). [Link]
36.
Carlsson E, Bosaeus I, Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr 2003; 22: 445–452. [Link]
37.
Slater R. High-output stomas: challenges with a large laparostomy wound. Br J Nurs 2012; 21: 28–33. [Link]
38.
Winkler M, Smith C. Clinical, social, and economic impacts of home parenteral nutrition dependence in short bowel syndrome. J Parenter Enter Nutr 2014; 38: 32–37. [Link]

Abstract

Short bowel is a condition that occurs after single or multiple intestinal resections. The incidence of short bowel in Europe is 2 per million of the population and it carries with it lifelong morbidity and mortality. The initial recognition and management of short bowel in the adult population tends to occur in the postoperative period and in the secondary care setting, where specialist input from clinicians experienced in short bowel is often lacking.

Topics

Small Intestine & Nutrition

Citation

Oke SM, Nightingale JM and Gabe SM Mistakes in short bowel and how to avoid them. UEG Education 2018; 18: 7–11.

Published

2018

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Mistakes in Familial Mediterranean Fever and how to avoid them

Mistakes in Familial Mediterranean Fever and how to avoid them

Gagik Hakobyan Gagik Hakobyan, Manik Gemilyan

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in transitional care for children and young adults and how  to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in rumination syndrome and how to avoid them

Alberto Ezquerra-Durán, Elizabeth Barba Orozco

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9
1.
Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124: 1111–1134. [Link]
2.
Mughal M, Irving M. Home parenteral nutrition in the United Kingdom and Ireland. Lancet 1986; 328: 383–387. [Link]
3.
Bakker H. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN-Home Artif Nutr Work Group Clin Nutr 1999; 18: 135–140. [Link]
4.
Gondolesi GE. Intestinal transplantation outcomes. Mt Sinai J Med 2012; 79: 246–255. [Link]
5.
Ahrens EJ, Blankenhorn D, Hirsch J. Measurement of the human intestinal length in vivo and some causes of variation. Gastroenterology 1956; 31: 274–284. [Link]
6.
Nightingale J, Lennard-Jones J. The short bowel syndrome: what’s new and old? Dig Dis 1993; 11: 12–31. [Link]
7.
Underhill BM. Intestinal length in man. Br Med J 1955; 2: 1243–1246. [Link]
8.
NICE. Clinical guideline [CG174]: Intravenous fluid therapy in adults in hospital, https://www.nice.org.uk/guidance/cg174/chapter/1-Recommendations#routine-maintenance-2 (2017, accessed 13 February 2018). [Link]
9.
Gabe SN. Small intestine. In: Standring S (ed.) Gray’s Anatomy : The anatomical basis of clinical practice. Elsevier Ltd, 2016, pp. 1124–1129. [Link]
10.
Baker ML, Williams R, Nightingale JMD. Causes and management of a high-output stoma. Colorectal Dis 2011; 13: 191–197. [Link]
11.
Gabe SM. OP033 The management of patients with high output enterocutaneous fistulae: A European survey. Clinical Nutrition Supplements 2012; 7: 14–15. [Link]
12.
Vallee BL, Wacker W, Ulmer DD. The magnesium-deficiency tetany syndrome in man. N Engl J Med 1960; 262: 155–161. [Link]
13.
Yu ASL, Yarlagadda SG. Hypomagnesemia: Clinical manifestations of magnesium depletion - UpToDate. UpToDate, https://www.uptodate.com/contents/hypomagnesemia-clinical-manifestations-of-magnesium-depletion (2025, accessed 13 February 2018). [Link]
14.
Staun M. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr 2009; 28: 467–479. [Link]
15.
Nightingale J. Guidelines for management of patients with a short bowel. Gut 2006; 55: 1–12. [Link]
16.
Pironi L. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr 2016; 35: 247–307. [Link]
17.
American Medical Association. Guidelines for essential trace element preparations for parenteral use: A statement by the Nutrition Advisory Group. J Parenter Enter Nutr 1979; 3: 263–267. [Link]
18.
Nightingale JM. Jejunal efflux in short bowel syndrome. Lancet 1990; 336: 765–768. [Link]
19.
Newton CR. Incidence and treatment of sodium depletion in ileostomists. Scand J Gastroenterol Suppl 1982; 74: 159–160. [Link]
20.
Newton CR. Effect of different drinks on fluid and electrolyte losses from a jejunostomy. J R Soc Med 1985; 78: 27–34. [Link]
21.
Lennard-Jones JE. Oral rehydration solutions in short bowel syndrome. Clin Ther 1990; 12: 129-137. [Link]
22.
Nightingale JM. Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution, and glucose polymer electrolyte solution. Gut 1992; 33: 759–761. [Link]
23.
Awouters F, Niemegeers C, Janssen PAJ. Pharmacology of antidiarrheal drugs. Annu Rev Pharmacol Toxicol 1983; 23: 279–301. [Link]
24.
Remington M, Fleming C, Malagelada J. Inhibition of postprandial pancreatic and biliary secretion by loperamide in patients with short bowel syndrome. Gut 1982; 23: 98–101. [Link]
25.
Lennard-Jones JE. Review article: practical management of the short bowel. Aliment Pharmacol Ther 1994; 8: 563–577. [Link]
26.
European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC). PRAC recommendations on signals, http://www.ema.europa.eu/docs/en_GB/document_library/PRAC_recommendation_on_signal/2017/03/WC500223722.pdf. (2017, accessed 20 October 2017). [Link]
27.
Food and Drug Admisitration (FDA). FDA Drug Safety Communication: FDA limits packaging for anti-diarrhea medicine Loperamide (Imodium) to encourage safe use, https://www.fda.gov/Drugs/DrugSafety/ucm594232.htm. (2018, accessed 15 February 2027). [Link]
28.
Nightingale JM. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 1991; 5: 405–412. [Link]
29.
Nightingale JM. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther 1989; 3: 367–373. [Link]
30.
Farthing MJ. Octreotide in dumping and short bowel syndromes. Digestion 1993; 54: 47–52. [Link]
31.
McIntyre P, Fitchew M. L-J. Patients with a high jejunostomy do not need a special diet. Gastroenterology 1986; 91: 25–33. [Link]
32.
Oke S, Walter MNM, Ansari T, et al. Growth factors and their use in short bowel. Curr Opin Gastroenterol 2017; 33: 212. [Link]
33.
Iyer KR, Kunecki M, Boullata JI, et al. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome. J Parenter Enter Nutr 2017; 41: 946–951. [Link]
34.
Schwartz LK, O’Keefe SJD, Fujioka K, et al. Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome. Clin Transl Gastroenterol 2016; 7: e142. [Link]
35.
Oke S, Nightingale J, Jeppesen J, et al. British Intestinal Failure Alliance (BIFA) position statement use of GLP-2 analogues and other growth factors for adult patients with intestinal failure., www.bapen.org.uk/pdfs/bifa/position-statements/use-of-glp-2-analogues-and-other-growth-factors-for-adult-patients-with-intestinal-failure.pdf (2023, accessed 26 June 2025). [Link]
36.
Carlsson E, Bosaeus I, Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr 2003; 22: 445–452. [Link]
37.
Slater R. High-output stomas: challenges with a large laparostomy wound. Br J Nurs 2012; 21: 28–33. [Link]
38.
Winkler M, Smith C. Clinical, social, and economic impacts of home parenteral nutrition dependence in short bowel syndrome. J Parenter Enter Nutr 2014; 38: 32–37. [Link]

Abstract

Topics

Neurogastroenterology & Motility

Citation

Ezquerra-Durán A and Barba-Orozco E. Mistakes in rumination syndrome and how to avoid them. UEG Education 2025; 25: 10-13.

Published

2025

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Mistakes in Familial Mediterranean Fever and how to avoid them

Mistakes in Familial Mediterranean Fever and how to avoid them

Gagik Hakobyan Gagik Hakobyan, Manik Gemilyan

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in transitional care for children and young adults and how  to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Mario Dinis-Ribeiro, Pradeep Mundre

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Stomach & H. Pylori

Published

2025

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Mistakes in Familial Mediterranean Fever and how to avoid them

Mistakes in Familial Mediterranean Fever and how to avoid them

Gagik Hakobyan Gagik Hakobyan, Manik Gemilyan

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in transitional care for children and young adults and how  to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in Familial Mediterranean Fever and how to avoid them

Manik Gemilyan, Gagik Hakobyan

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9
1.
Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124: 1111–1134. [Link]
2.
Mughal M, Irving M. Home parenteral nutrition in the United Kingdom and Ireland. Lancet 1986; 328: 383–387. [Link]
3.
Bakker H. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN-Home Artif Nutr Work Group Clin Nutr 1999; 18: 135–140. [Link]
4.
Gondolesi GE. Intestinal transplantation outcomes. Mt Sinai J Med 2012; 79: 246–255. [Link]
5.
Ahrens EJ, Blankenhorn D, Hirsch J. Measurement of the human intestinal length in vivo and some causes of variation. Gastroenterology 1956; 31: 274–284. [Link]
6.
Nightingale J, Lennard-Jones J. The short bowel syndrome: what’s new and old? Dig Dis 1993; 11: 12–31. [Link]
7.
Underhill BM. Intestinal length in man. Br Med J 1955; 2: 1243–1246. [Link]
8.
NICE. Clinical guideline [CG174]: Intravenous fluid therapy in adults in hospital, https://www.nice.org.uk/guidance/cg174/chapter/1-Recommendations#routine-maintenance-2 (2017, accessed 13 February 2018). [Link]
9.
Gabe SN. Small intestine. In: Standring S (ed.) Gray’s Anatomy : The anatomical basis of clinical practice. Elsevier Ltd, 2016, pp. 1124–1129. [Link]
10.
Baker ML, Williams R, Nightingale JMD. Causes and management of a high-output stoma. Colorectal Dis 2011; 13: 191–197. [Link]
11.
Gabe SM. OP033 The management of patients with high output enterocutaneous fistulae: A European survey. Clinical Nutrition Supplements 2012; 7: 14–15. [Link]
12.
Vallee BL, Wacker W, Ulmer DD. The magnesium-deficiency tetany syndrome in man. N Engl J Med 1960; 262: 155–161. [Link]
13.
Yu ASL, Yarlagadda SG. Hypomagnesemia: Clinical manifestations of magnesium depletion - UpToDate. UpToDate, https://www.uptodate.com/contents/hypomagnesemia-clinical-manifestations-of-magnesium-depletion (2025, accessed 13 February 2018). [Link]
14.
Staun M. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr 2009; 28: 467–479. [Link]
15.
Nightingale J. Guidelines for management of patients with a short bowel. Gut 2006; 55: 1–12. [Link]
16.
Pironi L. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr 2016; 35: 247–307. [Link]
17.
American Medical Association. Guidelines for essential trace element preparations for parenteral use: A statement by the Nutrition Advisory Group. J Parenter Enter Nutr 1979; 3: 263–267. [Link]
18.
Nightingale JM. Jejunal efflux in short bowel syndrome. Lancet 1990; 336: 765–768. [Link]
19.
Newton CR. Incidence and treatment of sodium depletion in ileostomists. Scand J Gastroenterol Suppl 1982; 74: 159–160. [Link]
20.
Newton CR. Effect of different drinks on fluid and electrolyte losses from a jejunostomy. J R Soc Med 1985; 78: 27–34. [Link]
21.
Lennard-Jones JE. Oral rehydration solutions in short bowel syndrome. Clin Ther 1990; 12: 129-137. [Link]
22.
Nightingale JM. Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution, and glucose polymer electrolyte solution. Gut 1992; 33: 759–761. [Link]
23.
Awouters F, Niemegeers C, Janssen PAJ. Pharmacology of antidiarrheal drugs. Annu Rev Pharmacol Toxicol 1983; 23: 279–301. [Link]
24.
Remington M, Fleming C, Malagelada J. Inhibition of postprandial pancreatic and biliary secretion by loperamide in patients with short bowel syndrome. Gut 1982; 23: 98–101. [Link]
25.
Lennard-Jones JE. Review article: practical management of the short bowel. Aliment Pharmacol Ther 1994; 8: 563–577. [Link]
26.
European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC). PRAC recommendations on signals, http://www.ema.europa.eu/docs/en_GB/document_library/PRAC_recommendation_on_signal/2017/03/WC500223722.pdf. (2017, accessed 20 October 2017). [Link]
27.
Food and Drug Admisitration (FDA). FDA Drug Safety Communication: FDA limits packaging for anti-diarrhea medicine Loperamide (Imodium) to encourage safe use, https://www.fda.gov/Drugs/DrugSafety/ucm594232.htm. (2018, accessed 15 February 2027). [Link]
28.
Nightingale JM. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 1991; 5: 405–412. [Link]
29.
Nightingale JM. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther 1989; 3: 367–373. [Link]
30.
Farthing MJ. Octreotide in dumping and short bowel syndromes. Digestion 1993; 54: 47–52. [Link]
31.
McIntyre P, Fitchew M. L-J. Patients with a high jejunostomy do not need a special diet. Gastroenterology 1986; 91: 25–33. [Link]
32.
Oke S, Walter MNM, Ansari T, et al. Growth factors and their use in short bowel. Curr Opin Gastroenterol 2017; 33: 212. [Link]
33.
Iyer KR, Kunecki M, Boullata JI, et al. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome. J Parenter Enter Nutr 2017; 41: 946–951. [Link]
34.
Schwartz LK, O’Keefe SJD, Fujioka K, et al. Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome. Clin Transl Gastroenterol 2016; 7: e142. [Link]
35.
Oke S, Nightingale J, Jeppesen J, et al. British Intestinal Failure Alliance (BIFA) position statement use of GLP-2 analogues and other growth factors for adult patients with intestinal failure., www.bapen.org.uk/pdfs/bifa/position-statements/use-of-glp-2-analogues-and-other-growth-factors-for-adult-patients-with-intestinal-failure.pdf (2023, accessed 26 June 2025). [Link]
36.
Carlsson E, Bosaeus I, Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr 2003; 22: 445–452. [Link]
37.
Slater R. High-output stomas: challenges with a large laparostomy wound. Br J Nurs 2012; 21: 28–33. [Link]
38.
Winkler M, Smith C. Clinical, social, and economic impacts of home parenteral nutrition dependence in short bowel syndrome. J Parenter Enter Nutr 2014; 38: 32–37. [Link]

Abstract

Familial Mediterranean fever (FMF), also called periodic disease, Armenian disease, etc., is a prototypical autoinflammatory disorder where the underlying mechanism is the dysfunction of innate immunity, resulting in unprovoked episodes of inflammation.1 Although considered rare worldwide, it is prevalent in people of Mediterranean origin; however, one can expect to encounter patients in all parts of the modern world. FMF is a monogenic disease with autosomal recessive inheritance.2 Unlike other monogenic disorders, the diagnosis remains largely clinical, and it is important to understand the limitations of genetic testing. Another distinguishing feature is the well-established effectiveness of lifelong monotherapy with colchicine in preventing attacks and complications.3

Topics

Primary Care

Published

2025

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Mistakes in Familial Mediterranean Fever and how to avoid them

Mistakes in Familial Mediterranean Fever and how to avoid them

Gagik Hakobyan Gagik Hakobyan, Manik Gemilyan

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in transitional care for children and young adults and how  to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in ostomy management and how to avoid them

Revital Barkan, Ian White, Iris Dotan

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9
1.
Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124: 1111–1134. [Link]
2.
Mughal M, Irving M. Home parenteral nutrition in the United Kingdom and Ireland. Lancet 1986; 328: 383–387. [Link]
3.
Bakker H. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN-Home Artif Nutr Work Group Clin Nutr 1999; 18: 135–140. [Link]
4.
Gondolesi GE. Intestinal transplantation outcomes. Mt Sinai J Med 2012; 79: 246–255. [Link]
5.
Ahrens EJ, Blankenhorn D, Hirsch J. Measurement of the human intestinal length in vivo and some causes of variation. Gastroenterology 1956; 31: 274–284. [Link]
6.
Nightingale J, Lennard-Jones J. The short bowel syndrome: what’s new and old? Dig Dis 1993; 11: 12–31. [Link]
7.
Underhill BM. Intestinal length in man. Br Med J 1955; 2: 1243–1246. [Link]
8.
NICE. Clinical guideline [CG174]: Intravenous fluid therapy in adults in hospital, https://www.nice.org.uk/guidance/cg174/chapter/1-Recommendations#routine-maintenance-2 (2017, accessed 13 February 2018). [Link]
9.
Gabe SN. Small intestine. In: Standring S (ed.) Gray’s Anatomy : The anatomical basis of clinical practice. Elsevier Ltd, 2016, pp. 1124–1129. [Link]
10.
Baker ML, Williams R, Nightingale JMD. Causes and management of a high-output stoma. Colorectal Dis 2011; 13: 191–197. [Link]
11.
Gabe SM. OP033 The management of patients with high output enterocutaneous fistulae: A European survey. Clinical Nutrition Supplements 2012; 7: 14–15. [Link]
12.
Vallee BL, Wacker W, Ulmer DD. The magnesium-deficiency tetany syndrome in man. N Engl J Med 1960; 262: 155–161. [Link]
13.
Yu ASL, Yarlagadda SG. Hypomagnesemia: Clinical manifestations of magnesium depletion - UpToDate. UpToDate, https://www.uptodate.com/contents/hypomagnesemia-clinical-manifestations-of-magnesium-depletion (2025, accessed 13 February 2018). [Link]
14.
Staun M. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr 2009; 28: 467–479. [Link]
15.
Nightingale J. Guidelines for management of patients with a short bowel. Gut 2006; 55: 1–12. [Link]
16.
Pironi L. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr 2016; 35: 247–307. [Link]
17.
American Medical Association. Guidelines for essential trace element preparations for parenteral use: A statement by the Nutrition Advisory Group. J Parenter Enter Nutr 1979; 3: 263–267. [Link]
18.
Nightingale JM. Jejunal efflux in short bowel syndrome. Lancet 1990; 336: 765–768. [Link]
19.
Newton CR. Incidence and treatment of sodium depletion in ileostomists. Scand J Gastroenterol Suppl 1982; 74: 159–160. [Link]
20.
Newton CR. Effect of different drinks on fluid and electrolyte losses from a jejunostomy. J R Soc Med 1985; 78: 27–34. [Link]
21.
Lennard-Jones JE. Oral rehydration solutions in short bowel syndrome. Clin Ther 1990; 12: 129-137. [Link]
22.
Nightingale JM. Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution, and glucose polymer electrolyte solution. Gut 1992; 33: 759–761. [Link]
23.
Awouters F, Niemegeers C, Janssen PAJ. Pharmacology of antidiarrheal drugs. Annu Rev Pharmacol Toxicol 1983; 23: 279–301. [Link]
24.
Remington M, Fleming C, Malagelada J. Inhibition of postprandial pancreatic and biliary secretion by loperamide in patients with short bowel syndrome. Gut 1982; 23: 98–101. [Link]
25.
Lennard-Jones JE. Review article: practical management of the short bowel. Aliment Pharmacol Ther 1994; 8: 563–577. [Link]
26.
European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC). PRAC recommendations on signals, http://www.ema.europa.eu/docs/en_GB/document_library/PRAC_recommendation_on_signal/2017/03/WC500223722.pdf. (2017, accessed 20 October 2017). [Link]
27.
Food and Drug Admisitration (FDA). FDA Drug Safety Communication: FDA limits packaging for anti-diarrhea medicine Loperamide (Imodium) to encourage safe use, https://www.fda.gov/Drugs/DrugSafety/ucm594232.htm. (2018, accessed 15 February 2027). [Link]
28.
Nightingale JM. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 1991; 5: 405–412. [Link]
29.
Nightingale JM. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther 1989; 3: 367–373. [Link]
30.
Farthing MJ. Octreotide in dumping and short bowel syndromes. Digestion 1993; 54: 47–52. [Link]
31.
McIntyre P, Fitchew M. L-J. Patients with a high jejunostomy do not need a special diet. Gastroenterology 1986; 91: 25–33. [Link]
32.
Oke S, Walter MNM, Ansari T, et al. Growth factors and their use in short bowel. Curr Opin Gastroenterol 2017; 33: 212. [Link]
33.
Iyer KR, Kunecki M, Boullata JI, et al. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome. J Parenter Enter Nutr 2017; 41: 946–951. [Link]
34.
Schwartz LK, O’Keefe SJD, Fujioka K, et al. Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome. Clin Transl Gastroenterol 2016; 7: e142. [Link]
35.
Oke S, Nightingale J, Jeppesen J, et al. British Intestinal Failure Alliance (BIFA) position statement use of GLP-2 analogues and other growth factors for adult patients with intestinal failure., www.bapen.org.uk/pdfs/bifa/position-statements/use-of-glp-2-analogues-and-other-growth-factors-for-adult-patients-with-intestinal-failure.pdf (2023, accessed 26 June 2025). [Link]
36.
Carlsson E, Bosaeus I, Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr 2003; 22: 445–452. [Link]
37.
Slater R. High-output stomas: challenges with a large laparostomy wound. Br J Nurs 2012; 21: 28–33. [Link]
38.
Winkler M, Smith C. Clinical, social, and economic impacts of home parenteral nutrition dependence in short bowel syndrome. J Parenter Enter Nutr 2014; 38: 32–37. [Link]

Abstract

Ostomy management refers to the care and maintenance of an ostomy and involves various aspects to ensure the individual’s health, comfort, and quality of life. This should involve the patient, a close support system (family and/or friends), and a healthcare team, including ostomy nurses and healthcare professionals specialising in ostomy care.

Topics

Primary Care

Published

2025

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Mistakes in Familial Mediterranean Fever and how to avoid them

Mistakes in Familial Mediterranean Fever and how to avoid them

Gagik Hakobyan Gagik Hakobyan, Manik Gemilyan

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in transitional care for children and young adults and how  to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra, Hans Törnblom, Jorge Amil Dias, Moriam Mustapha

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8 Mistake 9
1.
Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124: 1111–1134. [Link]
2.
Mughal M, Irving M. Home parenteral nutrition in the United Kingdom and Ireland. Lancet 1986; 328: 383–387. [Link]
3.
Bakker H. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN-Home Artif Nutr Work Group Clin Nutr 1999; 18: 135–140. [Link]
4.
Gondolesi GE. Intestinal transplantation outcomes. Mt Sinai J Med 2012; 79: 246–255. [Link]
5.
Ahrens EJ, Blankenhorn D, Hirsch J. Measurement of the human intestinal length in vivo and some causes of variation. Gastroenterology 1956; 31: 274–284. [Link]
6.
Nightingale J, Lennard-Jones J. The short bowel syndrome: what’s new and old? Dig Dis 1993; 11: 12–31. [Link]
7.
Underhill BM. Intestinal length in man. Br Med J 1955; 2: 1243–1246. [Link]
8.
NICE. Clinical guideline [CG174]: Intravenous fluid therapy in adults in hospital, https://www.nice.org.uk/guidance/cg174/chapter/1-Recommendations#routine-maintenance-2 (2017, accessed 13 February 2018). [Link]
9.
Gabe SN. Small intestine. In: Standring S (ed.) Gray’s Anatomy : The anatomical basis of clinical practice. Elsevier Ltd, 2016, pp. 1124–1129. [Link]
10.
Baker ML, Williams R, Nightingale JMD. Causes and management of a high-output stoma. Colorectal Dis 2011; 13: 191–197. [Link]
11.
Gabe SM. OP033 The management of patients with high output enterocutaneous fistulae: A European survey. Clinical Nutrition Supplements 2012; 7: 14–15. [Link]
12.
Vallee BL, Wacker W, Ulmer DD. The magnesium-deficiency tetany syndrome in man. N Engl J Med 1960; 262: 155–161. [Link]
13.
Yu ASL, Yarlagadda SG. Hypomagnesemia: Clinical manifestations of magnesium depletion - UpToDate. UpToDate, https://www.uptodate.com/contents/hypomagnesemia-clinical-manifestations-of-magnesium-depletion (2025, accessed 13 February 2018). [Link]
14.
Staun M. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr 2009; 28: 467–479. [Link]
15.
Nightingale J. Guidelines for management of patients with a short bowel. Gut 2006; 55: 1–12. [Link]
16.
Pironi L. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr 2016; 35: 247–307. [Link]
17.
American Medical Association. Guidelines for essential trace element preparations for parenteral use: A statement by the Nutrition Advisory Group. J Parenter Enter Nutr 1979; 3: 263–267. [Link]
18.
Nightingale JM. Jejunal efflux in short bowel syndrome. Lancet 1990; 336: 765–768. [Link]
19.
Newton CR. Incidence and treatment of sodium depletion in ileostomists. Scand J Gastroenterol Suppl 1982; 74: 159–160. [Link]
20.
Newton CR. Effect of different drinks on fluid and electrolyte losses from a jejunostomy. J R Soc Med 1985; 78: 27–34. [Link]
21.
Lennard-Jones JE. Oral rehydration solutions in short bowel syndrome. Clin Ther 1990; 12: 129-137. [Link]
22.
Nightingale JM. Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution, and glucose polymer electrolyte solution. Gut 1992; 33: 759–761. [Link]
23.
Awouters F, Niemegeers C, Janssen PAJ. Pharmacology of antidiarrheal drugs. Annu Rev Pharmacol Toxicol 1983; 23: 279–301. [Link]
24.
Remington M, Fleming C, Malagelada J. Inhibition of postprandial pancreatic and biliary secretion by loperamide in patients with short bowel syndrome. Gut 1982; 23: 98–101. [Link]
25.
Lennard-Jones JE. Review article: practical management of the short bowel. Aliment Pharmacol Ther 1994; 8: 563–577. [Link]
26.
European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC). PRAC recommendations on signals, http://www.ema.europa.eu/docs/en_GB/document_library/PRAC_recommendation_on_signal/2017/03/WC500223722.pdf. (2017, accessed 20 October 2017). [Link]
27.
Food and Drug Admisitration (FDA). FDA Drug Safety Communication: FDA limits packaging for anti-diarrhea medicine Loperamide (Imodium) to encourage safe use, https://www.fda.gov/Drugs/DrugSafety/ucm594232.htm. (2018, accessed 15 February 2027). [Link]
28.
Nightingale JM. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 1991; 5: 405–412. [Link]
29.
Nightingale JM. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther 1989; 3: 367–373. [Link]
30.
Farthing MJ. Octreotide in dumping and short bowel syndromes. Digestion 1993; 54: 47–52. [Link]
31.
McIntyre P, Fitchew M. L-J. Patients with a high jejunostomy do not need a special diet. Gastroenterology 1986; 91: 25–33. [Link]
32.
Oke S, Walter MNM, Ansari T, et al. Growth factors and their use in short bowel. Curr Opin Gastroenterol 2017; 33: 212. [Link]
33.
Iyer KR, Kunecki M, Boullata JI, et al. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome. J Parenter Enter Nutr 2017; 41: 946–951. [Link]
34.
Schwartz LK, O’Keefe SJD, Fujioka K, et al. Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome. Clin Transl Gastroenterol 2016; 7: e142. [Link]
35.
Oke S, Nightingale J, Jeppesen J, et al. British Intestinal Failure Alliance (BIFA) position statement use of GLP-2 analogues and other growth factors for adult patients with intestinal failure., www.bapen.org.uk/pdfs/bifa/position-statements/use-of-glp-2-analogues-and-other-growth-factors-for-adult-patients-with-intestinal-failure.pdf (2023, accessed 26 June 2025). [Link]
36.
Carlsson E, Bosaeus I, Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr 2003; 22: 445–452. [Link]
37.
Slater R. High-output stomas: challenges with a large laparostomy wound. Br J Nurs 2012; 21: 28–33. [Link]
38.
Winkler M, Smith C. Clinical, social, and economic impacts of home parenteral nutrition dependence in short bowel syndrome. J Parenter Enter Nutr 2014; 38: 32–37. [Link]

Abstract

Children and adolescents with chronic diseases requiring lifelong care face unique challenges that affect their daily lives and those of their families. Initially, these patients receive specialized care in pediatric facilities, where parents play a key role in treatment decisions. However, transitioning to adult healthcare facilities is inevitable, and this process, recognized as crucial years ago, involves moving adolescents with chronic conditions from child-centered to adult-oriented care. This transition can be complicated by varying age limits for pediatric care and the scarcity of adult care centers with specific expertise. The transition often requires cooperation between different centers or even countries due to patient mobility. The transition phase is critical, as it can lead to loss of follow-up, treatment suspension, and increased risks of complications or disease relapse. Beyond medical management, various factors influence the long-term prognosis of chronic conditions, making a well-organized transition program essential. While many hospitals have implemented transition models with mixed results in satisfaction, disease control, and follow-up adherence, there are frequent shortcomings in the process. This Mistakes In article will outline eight common mistakes made during the transition from pediatric to adult care, supported by literature and professional experience.

Topics

Primary Care

Citation

Jorge Amil-Dias, Hans Törnblom, Moriam Mustapha and Patrizia Burra. Mistakes in transitional care for children and young adults and how to avoid them. UEG Education 2023; 23: 22-25.

Published

2023

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Mistakes in Familial Mediterranean Fever and how to avoid them

Mistakes in Familial Mediterranean Fever and how to avoid them

Gagik Hakobyan Gagik Hakobyan, Manik Gemilyan

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in transitional care for children and young adults and how  to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

MASLD with Sven Francque - Part 2

Sven Francque, Pradeep Mundre

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Hepatobiliary

Published

2026

More Like This:

Mistakes in rumination syndrome and how to avoid them

Mistakes in rumination syndrome and how to avoid them

Elizabeth Barba Orozco Elizabeth Barba Orozco, Alberto Ezquerra-Durán

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Management of gastric preneoplastic lesions (MAPS 3) - what’s new? With Mario Dinis-Ribeiro (Part 2)

Pradeep Mundre Pradeep Mundre, Mario Dinis-Ribeiro

Mistakes in Familial Mediterranean Fever and how to avoid them

Mistakes in Familial Mediterranean Fever and how to avoid them

Gagik Hakobyan Gagik Hakobyan, Manik Gemilyan

Mistakes in ostomy management and how to avoid them

Mistakes in ostomy management and how to avoid them

Ian White Ian White, Iris Dotan, Revital Barkan

Mistakes in transitional care for children and young adults and how  to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

MASLD with Sven Francque - Part 2

MASLD with Sven Francque - Part 2

Pradeep Mundre Pradeep Mundre, Sven Francque

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.